Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
88,851,615
-
Share change
-
+5,711,055
-
Total reported value
-
$7,501,057,970
-
Put/Call ratio
-
64%
-
Price per share
-
$84.43
-
Number of holders
-
293
-
Value change
-
+$476,297,870
-
Number of buys
-
148
-
Number of sells
-
146
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q2 2019
As of 30 Jun 2019 NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) had 293 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 88,851,615 shares of stock of the company.
Largest 10 holders included JANUS HENDERSON GROUP PLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., Capital International Investors, PERCEPTIVE ADVISORS LLC, Bellevue Group AG, PRICE T ROWE ASSOCIATES INC /MD/, HealthCor Management, L.P., and STATE STREET CORP.
This table shows 294 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.